Substance / Medication

Paromomycin sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Global systematic review of patients with cerebral amebiasis: Successful and rapid clinical and paraclinical diagnostic methods.
Marzban Arman, Ghasemikhah Reza · Diagn Microbiol Infect Dis · 2025
PMID: 40602053Meta-Analysis
Prevalence of Amoebiasis and Associated Complications in India: A Systematic Review.
Gupta Palak, Singh Kiran Kumari, Balodhi Ashutosh et al. · Acta Parasitol · 2022
PMID: 35404011Meta-Analysis
Medicinal Plants with anti-Acanthamoeba Activity: A Systematic Review.
Chegeni Tooran Nayeri, Fakhar Mahdi, Ghaffarifar Fatemeh et al. · Infect Disord Drug Targets · 2020
PMID: 31322072Meta-Analysis
Amebic acute appendicitis: systematic review of 174 cases.
Otan Emrah, Akbulut Sami, Kayaalp Cuneyt · World J Surg · 2013
PMID: 23665815Meta-Analysis
Evaluation of bithionol as a bath treatment for amoebic gill disease caused by Neoparamoeba spp.
Florent Renee L, Becker Joy A, Powell Mark D · Vet Parasitol · 2007
PMID: 17129675RCT
Balamuthia mandrillaris - a brief overview of the parasite causing encephalitis.
Siddiqui Ruqaiyyah, Rizvi Zainab Salman, Maciver Sutherland K et al. · Microb Pathog · 2026
PMID: 41260546Review
Acanthamoeba spp.: Neglected Protists in Veterinary Medicine.
Bahrami Somayeh, Zarei Mehdi, Henriquez Fiona L et al. · Acta Parasitol · 2025
PMID: 40210735Review
[NAEGLERIA FOWLERI AMOEBA MENINGITIS - REVIEW AND UPDATE].
Edelman Lior, Tocut Milena, Zandman-Goddard Gisele · Harefuah · 2025
PMID: 40257316Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Paromomycin sulfate (substance)
SNOMED CT
30203009
UMLS CUI
C0205881

Clinical Data

This intervention maps to 7 entities in the Ltrl knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.